Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 606 recruiting now below national open share #27 of 52 states

Kansas: below-average open trial sites

606 of 2,080 in-state trials are recruiting (29%); below the 37% national average by 8 percentage points.

According to ClinicalTrials.gov-derived indexes, Kansas sits in the lower half of US states by in-state trial count (#27 of 52 states by registered in-state trial count).

Kansas: 2,080 US clinical trials with in-state sites, 606 recruiting.

Kansas has 2,080 registered US clinical trials with a study site in-state, 606 of them currently recruiting (below the 37% national average by 8 percentage points). 532 of these trials are in Phase 3 (late-stage) and 518 in Phase 2. The most frequently studied condition in Kansas is Healthy, with 37 linked trials.

Lower-half Kansas archive

Kansas's in-state trials target 925 patients on average (p14 by trial size among 52 states with enrollment data), smaller studies than most states. Treat this page as a compact local index (mid-volume · low-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.

Below-average open enrollment

Kansas still shows 606 recruiting of 2,080 in-state trials (29% open), but below the 37% national average by 8 percentage points, so archived statuses weigh heavier than the national baseline.

29%
open (below national share)
606
still recruiting despite cool share
518
Phase 2 rows in this footprint
37
top: Healthy

Recruiting share is below the 37% national average by 8 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.

Kansas vs all states by indexed in-state trial count

Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)

2,080 Top 52% more indexed trials than 48% of 52 states

States, banded by indexed in-state trial count

Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov · 2026-08-08

Key findings

What ClinicalTrials.gov does not surface for Kansas on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Kansas open-enrollment share sits below the national baseline.

    606 of 2,080 in-state trials (29.1%) are recruiting, against 37% nationally (-7.9 percentage points). Counts include every study with at least one recorded site in the state.

  2. Kansas trial sites spread across 8 city hubs.

    Kansas City lists 877 of 2,080 in-state trials (42.2%) across 213 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.

  3. Healthy is the most-studied condition in Kansas.

    37 of 2,080 in-state trials (1.8%) list Healthy. That is a local concentration figure, not a national disease ranking.

  4. Kansas sponsorship is fragmented across many organizations.

    University of Kansas Medical Center appears on 160 of 2,080 in-state trials (7.7%). Sponsor identity is as filed on ClinicalTrials.gov.

  5. 967 Kansas trials carry a completed status.

    967 of 2,080 (46.5%) are completed. The open share above is the remainder that still lists recruiting.

Phase 3532Phase 2518Phase 1389NA341Phase 470Early Phase 17
Treemap Treemap of 15 categories, sized proportional to value. Healthy 37 Breast Cancer 35 Prostate Cancer 32 Cystic Fibrosis 28 Non-Small Ce… 25 Obesity 25 Multiple Myeloma 24 Multiple Sclerosis 23 Coronary Art… 18 Parkinson Di… 18 Heart Failure 18 Acute Myeloid… 16 Parkinson's Disease 15 Influenza 15 Diabetes Mellitus, Type 2 15

By Status

StatusTrial count
Completed 967
Recruiting 606
Active 507

By Phase

PhaseTrial count
Phase 3 532
Phase 2 518
Phase 1 389
NA 341
Phase 4 70
Early Phase 1 7

Where trials run in Kansas

Kansas City carries 877 of Kansas's 2,080 indexed trials (42%) across 213 named sites, ahead of Overland Park at 343. 8 cities clear five listed trials, together naming 776 distinct sites.

City Trials Listed sites
Kansas City 877 213
Overland Park 343 170
Wichita 329 153
Westwood 226 58
Fairway 144 50
Lenexa 114 63
Topeka 99 53
Pittsburg 55 16

Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.

Trial size small

Kansas's in-state trials target 925 patients on average (p14 by trial size among 52 states with enrollment data), smaller studies than most states.

Kansas: in-state trial volume sits mid-pack

Sites spread across 8 cities with five or more listed trials, led by Kansas City (877, 42% of the state total) and Overland Park (343), together naming 776 distinct research locations.

Phase mix: 532 Phase 3 vs 518 Phase 2 (balanced across stages).

Top condition: Healthy (37 trials); top sponsor University of Kansas Medical Center (160).

mid-volume · low-open figures (2,080 trials · 29% open) describe registry geography under the trial size small read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.

States near Kansas on in-state trial volume

Cross-state peers under the trial size small read (mid-volume · low-open), not the same-state browse list.

Similar mid-volume peers (± open share)

Similar low-open peers (± trial volume)

  • New Mexico · 29% recruiting · 579 trials
  • Indiana · 29% recruiting · 3,113 trials
  • Alabama · 29% recruiting · 4,168 trials
  • Nebraska · 29% recruiting · 1,301 trials
  • Arkansas · 28% recruiting · 2,376 trials
Source: ClinicalTrials.gov, the US trial registry maintained by the National Library of Medicine, part of the NIH. Kansas series (mid-volume · low-open · trial size small) retrieved and formatted by PlainTrial, see methodology.